SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-056205
Filing Date
2021-11-10
Accepted
2021-11-10 16:16:14
Documents
75
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q abcl-10q_20210930.htm   iXBRL 10-Q 3571627
2 EX-31.1 abcl-ex311_7.htm EX-31.1 20974
3 EX-31.2 abcl-ex312_8.htm EX-31.2 20940
4 EX-32.1 abcl-ex321_6.htm EX-32.1 9468
5 EX-32.2 abcl-ex322_9.htm EX-32.2 9445
6 GRAPHIC gkqmw315cpek000001.jpg GRAPHIC 108576
  Complete submission text file 0001564590-21-056205.txt   9864121

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA abcl-20210930.xsd EX-101.SCH 50761
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abcl-20210930_cal.xml EX-101.CAL 65820
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abcl-20210930_def.xml EX-101.DEF 197170
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abcl-20210930_lab.xml EX-101.LAB 414967
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abcl-20210930_pre.xml EX-101.PRE 335777
12 EXTRACTED XBRL INSTANCE DOCUMENT abcl-10q_20210930_htm.xml XML 1530027
Mailing Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1
Business Address 2215 YUKON STREET VANCOUVER A1 V5Y 0A1 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39781 | Film No.: 211396835
SIC: 2834 Pharmaceutical Preparations